Global Therapeutic Vaccines Market Research Report 2026(Status and Outlook)

May 2026 | 130 pages | ID: G4328ABE1871EN
Bosson Research

Abstracts

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

The global Vaccines market size was estimated at USD 50450.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccines market.

Global Vaccines Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GSK
• Sanofi
• Merck
• Pfizer
• Novartis(GSK)
• CSL
• MedImmune LLC
• J&J(Crucell)
• China National Biotec
• Tiantan
• Hualan
• Kangtai
• Hissen
• Jintan

Market Segmentation (by Type)

• Recombinant Vaccines
• Viral Vaccines
• Polysaccharide Vaccines
• Others

Market Segmentation (by Application)

• Rabies vaccine
• Influenza vaccine
• HPV vaccine
• Hepatitis B
• Hepatitis A
• Leprosy vaccine
• Polio vaccine
• JE vaccine
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Vaccines Market

Overview of the regional outlook of the Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Therapeutic Vaccines
1.2 Key Market Segments
  1.2.1 Therapeutic Vaccines Segment by Type
  1.2.2 Therapeutic Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 THERAPEUTIC VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Therapeutic Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Therapeutic Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 THERAPEUTIC VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Therapeutic Vaccines Product Life Cycle
3.3 Global Therapeutic Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Therapeutic Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Therapeutic Vaccines Market Competitive Situation and Trends
  3.8.1 Therapeutic Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Therapeutic Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 THERAPEUTIC VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Therapeutic Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Therapeutic Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Therapeutic Vaccines Market
5.7 ESG Ratings of Leading Companies

6 THERAPEUTIC VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Therapeutic Vaccines Market Size by Type (2020-2025)
6.4 Global Therapeutic Vaccines Price by Type (2020-2025)

7 THERAPEUTIC VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Vaccines Market Sales by Application (2020-2025)
7.3 Global Therapeutic Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Therapeutic Vaccines Sales Growth Rate by Application (2020-2025)

8 THERAPEUTIC VACCINES MARKET SALES BY REGION

8.1 Global Therapeutic Vaccines Sales by Region
  8.1.1 Global Therapeutic Vaccines Sales by Region
  8.1.2 Global Therapeutic Vaccines Sales Market Share by Region
8.2 Global Therapeutic Vaccines Market Size by Region
  8.2.1 Global Therapeutic Vaccines Market Size by Region
  8.2.2 Global Therapeutic Vaccines Market Size by Region
8.3 North America
  8.3.1 North America Therapeutic Vaccines Sales by Country
  8.3.2 North America Therapeutic Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Therapeutic Vaccines Sales by Country
  8.4.2 Europe Therapeutic Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Therapeutic Vaccines Sales by Region
  8.5.2 Asia Pacific Therapeutic Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Therapeutic Vaccines Sales by Country
  8.6.2 South America Therapeutic Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Therapeutic Vaccines Sales by Region
  8.7.2 Middle East and Africa Therapeutic Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 THERAPEUTIC VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Therapeutic Vaccines by Region(2020-2025)
9.2 Global Therapeutic Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Therapeutic Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Therapeutic Vaccines Production
  9.4.1 North America Therapeutic Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Therapeutic Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Therapeutic Vaccines Production
  9.5.1 Europe Therapeutic Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Therapeutic Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Therapeutic Vaccines Production (2020-2025)
  9.6.1 Japan Therapeutic Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Therapeutic Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Therapeutic Vaccines Production (2020-2025)
  9.7.1 China Therapeutic Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Therapeutic Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Northeast Biotherapeutics
  10.1.1 Northeast Biotherapeutics Basic Information
  10.1.2 Northeast Biotherapeutics Therapeutic Vaccines Product Overview
  10.1.3 Northeast Biotherapeutics Therapeutic Vaccines Product Market Performance
  10.1.4 Northeast Biotherapeutics Business Overview
  10.1.5 Northeast Biotherapeutics SWOT Analysis
  10.1.6 Northeast Biotherapeutics Recent Developments
10.2 Agenus
  10.2.1 Agenus Basic Information
  10.2.2 Agenus Therapeutic Vaccines Product Overview
  10.2.3 Agenus Therapeutic Vaccines Product Market Performance
  10.2.4 Agenus Business Overview
  10.2.5 Agenus SWOT Analysis
  10.2.6 Agenus Recent Developments
10.3 Vaccinogen Inc
  10.3.1 Vaccinogen Inc Basic Information
  10.3.2 Vaccinogen Inc Therapeutic Vaccines Product Overview
  10.3.3 Vaccinogen Inc Therapeutic Vaccines Product Market Performance
  10.3.4 Vaccinogen Inc Business Overview
  10.3.5 Vaccinogen Inc SWOT Analysis
  10.3.6 Vaccinogen Inc Recent Developments
10.4 CIMAB S.A
  10.4.1 CIMAB S.A Basic Information
  10.4.2 CIMAB S.A Therapeutic Vaccines Product Overview
  10.4.3 CIMAB S.A Therapeutic Vaccines Product Market Performance
  10.4.4 CIMAB S.A Business Overview
  10.4.5 CIMAB S.A Recent Developments
10.5 Dendreon
  10.5.1 Dendreon Basic Information
  10.5.2 Dendreon Therapeutic Vaccines Product Overview
  10.5.3 Dendreon Therapeutic Vaccines Product Market Performance
  10.5.4 Dendreon Business Overview
  10.5.5 Dendreon Recent Developments
10.6 Corixa
  10.6.1 Corixa Basic Information
  10.6.2 Corixa Therapeutic Vaccines Product Overview
  10.6.3 Corixa Therapeutic Vaccines Product Market Performance
  10.6.4 Corixa Business Overview
  10.6.5 Corixa Recent Developments
10.7 AVAX Technologies
  10.7.1 AVAX Technologies Basic Information
  10.7.2 AVAX Technologies Therapeutic Vaccines Product Overview
  10.7.3 AVAX Technologies Therapeutic Vaccines Product Market Performance
  10.7.4 AVAX Technologies Business Overview
  10.7.5 AVAX Technologies Recent Developments

11 THERAPEUTIC VACCINES MARKET FORECAST BY REGION

11.1 Global Therapeutic Vaccines Market Size Forecast
11.2 Global Therapeutic Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Therapeutic Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Therapeutic Vaccines Market Size Forecast by Region
  11.2.4 South America Therapeutic Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Therapeutic Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Therapeutic Vaccines Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Therapeutic Vaccines by Type (2026-2035)
  12.1.2 Global Therapeutic Vaccines Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Therapeutic Vaccines by Type (2026-2035)
12.2 Global Therapeutic Vaccines Market Forecast by Application (2026-2035)
  12.2.1 Global Therapeutic Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Therapeutic Vaccines Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Therapeutic Vaccines Market Size by Type (M USD)
Table 4. Global Therapeutic Vaccines Market Size by Application
Table 5. Therapeutic Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Therapeutic Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Therapeutic Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Therapeutic Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Therapeutic Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2025)
Table 11. Global Market Therapeutic Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Therapeutic Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Therapeutic Vaccines Sales by Type (K MT)
Table 27. Global Therapeutic Vaccines Market Size by Type (M USD)
Table 28. Global Therapeutic Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Therapeutic Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Therapeutic Vaccines Market Share by Type (2020-2025)
Table 32. Global Therapeutic Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Therapeutic Vaccines Sales (K MT) by Application
Table 34. Global Therapeutic Vaccines Market Size by Application
Table 35. Global Therapeutic Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Therapeutic Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Therapeutic Vaccines Market Share by Application (2020-2025)
Table 39. Global Therapeutic Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Therapeutic Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Therapeutic Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Therapeutic Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Therapeutic Vaccines Market Size by Region (2020-2025)
Table 44. North America Therapeutic Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Therapeutic Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Therapeutic Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Therapeutic Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Therapeutic Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Therapeutic Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Therapeutic Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Therapeutic Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Therapeutic Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Therapeutic Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Therapeutic Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Therapeutic Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Therapeutic Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Therapeutic Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Therapeutic Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Therapeutic Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Therapeutic Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Therapeutic Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Northeast Biotherapeutics Basic Information
Table 63. Northeast Biotherapeutics Therapeutic Vaccines Product Overview
Table 64. Northeast Biotherapeutics Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Northeast Biotherapeutics Business Overview
Table 66. Northeast Biotherapeutics SWOT Analysis
Table 67. Northeast Biotherapeutics Recent Developments
Table 68. Agenus Basic Information
Table 69. Agenus Therapeutic Vaccines Product Overview
Table 70. Agenus Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Agenus Business Overview
Table 72. Agenus SWOT Analysis
Table 73. Agenus Recent Developments
Table 74. Vaccinogen Inc Basic Information
Table 75. Vaccinogen Inc Therapeutic Vaccines Product Overview
Table 76. Vaccinogen Inc Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Vaccinogen Inc Business Overview
Table 78. Vaccinogen Inc SWOT Analysis
Table 79. Vaccinogen Inc Recent Developments
Table 80. CIMAB S.A Basic Information
Table 81. CIMAB S.A Therapeutic Vaccines Product Overview
Table 82. CIMAB S.A Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CIMAB S.A Business Overview
Table 84. CIMAB S.A Recent Developments
Table 85. Dendreon Basic Information
Table 86. Dendreon Therapeutic Vaccines Product Overview
Table 87. Dendreon Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Dendreon Business Overview
Table 89. Dendreon Recent Developments
Table 90. Corixa Basic Information
Table 91. Corixa Therapeutic Vaccines Product Overview
Table 92. Corixa Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Corixa Business Overview
Table 94. Corixa Recent Developments
Table 95. AVAX Technologies Basic Information
Table 96. AVAX Technologies Therapeutic Vaccines Product Overview
Table 97. AVAX Technologies Therapeutic Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AVAX Technologies Business Overview
Table 99. AVAX Technologies Recent Developments
Table 100. Global Therapeutic Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Therapeutic Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Therapeutic Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Therapeutic Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Therapeutic Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Therapeutic Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Therapeutic Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Therapeutic Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Therapeutic Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Therapeutic Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Therapeutic Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Therapeutic Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Therapeutic Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Therapeutic Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Therapeutic Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Therapeutic Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Therapeutic Vaccines Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Therapeutic Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Therapeutic Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Therapeutic Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Therapeutic Vaccines Product Life Cycle
Figure 13. Therapeutic Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Therapeutic Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Therapeutic Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Therapeutic Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Therapeutic Vaccines
Figure 19. Global Therapeutic Vaccines Market PEST Analysis
Figure 20. Global Therapeutic Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Therapeutic Vaccines Market Share by Type
Figure 27. Sales Market Share of Therapeutic Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Therapeutic Vaccines by Type in 2025
Figure 29. Market Share of Therapeutic Vaccines by Type (2020-2025)
Figure 30. Market Share of Therapeutic Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Therapeutic Vaccines Market Share by Application
Figure 33. Global Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Therapeutic Vaccines Sales Market Share by Application in 2025
Figure 35. Global Therapeutic Vaccines Market Share by Application (2020-2025)
Figure 36. Global Therapeutic Vaccines Market Share by Application in 2025
Figure 37. Global Therapeutic Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Therapeutic Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Therapeutic Vaccines Market Size by Region (2020-2025)
Figure 40. North America Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Therapeutic Vaccines Sales Market Share by Country in 2024
Figure 43. North America Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Therapeutic Vaccines Market Size by Country in 2024
Figure 45. U.S. Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Therapeutic Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Therapeutic Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Therapeutic Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Therapeutic Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Therapeutic Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Therapeutic Vaccines Market Size by Country in 2024
Figure 55. Germany Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Therapeutic Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Therapeutic Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Therapeutic Vaccines Market Size by Region in 2024
Figure 68. China Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Therapeutic Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Therapeutic Vaccines Sales Market Share by Country in 2024
Figure 80. South America Therapeutic Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Therapeutic Vaccines Market Size by Country in 2024
Figure 82. Brazil Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Therapeutic Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Therapeutic Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Therapeutic Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Therapeutic Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Therapeutic Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Therapeutic Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Therapeutic Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Therapeutic Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Therapeutic Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Therapeutic Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Therapeutic Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Therapeutic Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Therapeutic Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Therapeutic Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Therapeutic Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Therapeutic Vaccines Market Share Forecast by Application (2026-2035)